Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis

Gynecologic Oncology

Volumn 93, Issue 1, 2004, Pages 107-111

  Juretzka, Margrit M ^a   Jensen, Kristin C ^a   Longacre, Teri A ^a   Teng, Nelson N ^a   Husain, Amreen ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cervical cancer; Cytokeratin; Immunohistochemical analysis; Lymph node metastasis; Micrometastasis

Indexed keywords

ANTIBODY; CYTOKERATIN; CYTOKERATIN ANTIBODY AE1; CYTOKERATIN ANTIBODY AE1 CAM5.2; UNCLASSIFIED DRUG;

ADULT; AGED; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; STAINING; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 1842425443     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.11.033     Document Type: Conference Paper

References (21)

1. Cancer Facts and Figures. 2003;American Cancer Society, Atlanta, GA.
2. Berek J.S., Hacker N.F. Practical Gynecologic Oncology. Third ed. 2000;Lippincott Williams and Wilkins, Philadelphia.
3. Delgado G., Bundy B., Zaino R., Sevin B.U., Creasman W.T., Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol. Oncol. 38(3):1990;352-357.
4. Morrow C.P., Curtin J.P. Synopsis of Gynecologic Oncology. Fifth ed. 1998;Livingstone, New York.
5. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A.et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340(15):1999;1144-1153.
6. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L. IIIet al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340(15):1999;1154-1161.
7. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E.et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 340(15):1999;1137-1143.
8. Peters W.A. III, Liu P.Y., Barrett R.J. II, Stock R.J., Monk B.J., Berek J.S.et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18(8):2000;1606- 1613.
9. Xu X., Roberts S.A., Pasha T.L., Zhang P.J. Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch. Pathol. Lab. Med. 124(9):2000;1310-1313.
10. Rampaul R.S., Miremadi A., Pinder S.E., Lee A., Ellis I.O. Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res. 3(2):2001;113-116.
11. Weaver D.L., Krag D.N., Ashikaga T., Harlow S.P., O'Connell M. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer. 88(5):2000;1099-1107.
12. Dowlatshahi K., Fan M., Snider H.C., Habib F.A. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. 80(7):1997;1188-1197.
13. Cote R.J., Peterson H.F., Chaiwun B., Gelber R.D., Goldhirsch A., Castiglione-Gertsch M.et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet. 354(9182):1999;896-900.
14. Fleming I.D., American Joint Committee on Cancer, American College of Surgeons, American Cancer Society AJCC Cancer Staging Manual. Fifth ed. 1997;Raven, Philadelphia.
15. Hermanek P., Hutter R.V., Sobin L.H., Wittekind C. International union against cancer. Classification of isolated tumor cells and micrometastasis. Cancer. 86(12):1999;2668-2673.
16. Greene F.L., American Joint Committee on Cancer, American Cancer Society AJCC Cancer Staging Manual. Sixth ed. 2002;Springer, New York.
17. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group. Lancet. 355(8705):1990;1565-1568.
18. Maddox P., Sasieni P., Szarewski A., Anderson M., Hanby A. Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma. J. Clin. Pathol. 52(1):1999;41-46.
19. Smedts F., Ramaekers F., Troyanovsky S., Pruszczynski M., Link M., Lane B.et al. Keratin expression in cervical cancer. Am. J. Pathol. 141(2):1992;497-511.
20. Van Trappen P.O., Gyselman V.G., Lowe D.G., Ryan A., Oram D.H., Bosze P.et al. Molecular quantification and mapping of lymph node micrometastases in cervical cancer. Lancet. 357(9249):2001;15-20.
21. Lentz S.E. Identification of micrometastases in histologically negative lymph nodes of early stage cervical cancer. Society of Gynecologic Oncologists, 33rd Annual Meeting, 2001. 2001;. 3/2-7/2001.